H5N1 influenza - Continuing evolution and spread

New England Journal of Medicine

Volumn 355, Issue 21, 2006, Pages 2174-2177

  Webster, Robert G ^a   Govorkova, Elena A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR;

AVIAN INFLUENZA; DISEASE TRANSMISSION; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; POULTRY; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION;

ANIMALS; ASIA; BIRDS; DISEASE OUTBREAKS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MUTATION; POULTRY;

EID: 33751231111     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp068205     Document Type: Short Survey

References (3)

1. Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 2006;194:159-67.
2. Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A 2005;102: 10682-7.
3. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440:435-6.